Galectin 3 is a ␤-galactoside binding protein which localizes to the cytoplasm of proliferative, mature, and hypertrophic chondrocytes in the growth plate cartilage of developing long bones. To elucidate the function of galectin 3 during bone development, we examined the epiphyseal femurs and tibias of fetal mice carrying a null mutation for the galectin 3 gene. Detailed histological and ultrastructural studies identified abnormalities in the cells of the proliferative, mature, and hypertrophic zones and in the extracellular matrix of the hypertrophic zone, as well as a reduction in the total number of hypertrophic chondrocytes. The expression patterns of several chondrocyte and bone cell markers were analyzed and revealed a subtle modification of Ihh expression in the galectin 3 mutant growth plate. A striking difference was observed at the chondrovascular junction where many empty lacunae are present. In addition, large numbers of condensed chondrocytes exhibiting characteristic signs of cell death were found in the late hypertrophic zone, indicating that the rate of chondrocyte death is increased in the mutants. These results suggest a role for galectin 3 as a regulator of chondrocyte survival. In addition, this unique phenotype shows that the elimination of chondrocytes and vascular invasion can be uncoupled and indicates that galectin 3 may play a role in the coordination between chondrocyte death and metaphyseal vascularization.
INTRODUCTION
The majority of the bones in the vertebrate skeleton form by endochondral ossification. This process is initiated in the embryo by mesenchymal condensations that give rise to cartilage elements, which in turn are invaded by blood vessels and gradually replaced by bone tissue. At the level of the growth plate cartilage, which is localized at the extremities of long bones, chondrocytes are organized into proliferative, mature, and hypertrophic zones where they play an important role in regulating bone elongation. In the terminal hypertrophic zone, chondrocytes undergo programmed cell death, calcified cartilage matrix is degraded, and the remaining cartilage septa serve as a scaffold for bone matrix deposition by osteoblasts (Hall, 1988; Poole, 1991) .
Perfect coordination between chondrocyte differentiation and bone formation is required for normal bone development, and in particular, perturbations in chondrocyte hypertrophy can severely affect endochondral ossification (Volk and Leboy, 1999; Wallis, 1993) . Hypertrophic chondrocytes play a crucial role in producing the components of the cartilage matrix and modifying its properties thus allowing vascular invasion and subsequent bone deposition (Caplan and Pechak, 1987 ).
An increasing number of molecules are known to play a role in controlling chondrocyte differentiation. For example, Bmp6 is a stimulator of chondrocyte differentiation (Grimsrud et al., 1999) while Indian hedgehog (Ihh), parathyroid hormone related-peptide (PTHrP), and its receptor negatively control the rate of chondrocyte maturation (Vortkamp et al., 1996; St-Jacques et al., 1999; Karp et al., 2000) . However, the relationships between terminal differentiation of chondrocytes, vascular invasion, and bone formation are less well understood, although matrix metalloproteinase 9 (MMP9) and vascular endothelial growth factor (VEGF) have both been shown to be involved in growth plate angiogenesis (Gerber et al., 1999; Vu et al., 1998) .
Here, we report that galectin 3, a molecule that belongs to the family of ␤-galactoside binding proteins, may play a role in endochondral ossification. Like other members of the same family, galectin 3 is a soluble protein that can be found intracellularly, in the nucleus or the cytoplasm, and extracellularly at the cell surface or in the matrix, depending on the cell type and the differentiation stage (Barondes et al., 1994) . Galectin 3 does not contain a signal sequence and its secretion is independent of the Golgi pathway (Lindstedt et al., 1993; Sato et al., 1993) . Its role outside the cell has been linked to modulation of cell adhesion in organogenesis, in the immune system, and during tumorigenesis (Bao and Hughes, 1995; Liu, 1993; Raz and Lotan, 1987) . Inside the cell, galectin 3 has also been implicated in splicing of mRNA and apoptosis of T-cells and tumor cells (Akahani et al., 1997; Dagher et al., 1995; Kim et al., 1999; Yang et al., 1996) .
We have previously shown that in the midgestation mouse embryo, the major site of galectin 3 expression is the cartilage (Fowlis et al., 1995) . Subcellular distribution of the protein in growth plate chondrocytes of fetal and neonatal mice is mainly cytoplasmic, with high amounts detectable in mature and early hypertrophic cells (Colnot et al., 1999) . These results suggested an intracellular function for galectin 3 in terminal differentiation of chondrocytes.
In this report, we describe several defects in chondrocyte differentiation in the long bones of galectin 3 null mutant embryos, both at the cellular and at the molecular level. The most striking abnormalities were observed at the chondrovascular junction where there was a reduced number of hypertrophic chondrocytes accompanied by an increased number of empty lacunae and condensed chondrocytes, indicating an acceleration of cell death in the absence of coordinated angiogenesis. This unique asynchrony between chondrocyte elimination and vascular invasion reveals that both processes can be uncoupled.
MATERIALS AND METHODS

Galectin 3 ؊/؊ Mutant Mice
WW6 embryonic stem cells carrying a null mutation of the galectin 3 gene were used to generate a chimeric male that was mated with a 129 wild-type female. Heterozygote offspring were intercrossed to establish the galectin 3 null strain. Homozygous animals are viable and fertile (Colnot et al., 1998) .
Reagents
Cacodylate, osmium, uranyl acetate, and lead citrate were purchased from Prolabo (France), Epon (Epox 812) from Ernest Fullam (NY, U.S.A.). Unless otherwise stated all reagents were from Sigma (France).
Tissue Preparation for Histology and for Electron Microscopy
Sixteen and a half day old fetal mice were extracted by cesarean section. Thirteen mutant embryos from five litters and 11 wildtype embryos from five litters were collected for this study. Femurs were dissected out and initially fixed by immersion for 2 h at 4°C in 2.5% glutaraldehyde, 0.1 M cacodylate, pH 7.4. After three washes in 0.1 M cacodylate, samples were fixed in 1% osmium tetroxide, 0.1 M cacodylate for 1 h. Tissues were processed without decalcification. They were dehydrated in a graded alcohol series and embedded in Epon. Infiltration was achieved by incubation in 1:1 alcohol:Epon for 4 (closed vials) and 16 h (opened vials), followed by pure Epon for 24 h. Embedded samples were incubated at 37°C for 16 h and polymerized at 60°C for 48 h.
Histological Analysis under Light Microscopy
Semithin longitudinal sections (0.5-1 m) of whole femurs were collected on polylysine-treated slides. Fifty serial sections of each sample were collected and stained with toluidine blue (pH 4 or 7). Counts reported in Table 1 were obtained from three different nonserial paramedian sections for each individual. The total number of hypertrophic chondrocytes was quantified by taking into account every cell between the end of the mature zone and the vascular invasion front. We have taken into account every cell with an enlarged volume and increased number of vacuoles characteristic of hypertrophic chondrocytes. Condensed chondrocytes were also taken into account, but flattened chondrocytes at the surface of the bones were not included. Quantification of condensed chondrocytes was performed at higher magnification in order to see cells with condensed cell contents and with a cytoplasmic membrane which had withdrawn from the edge of the lacunae. These cells were easily identified as they did not occupy the whole volume of the lacunae and were more strongly stained than hypertrophic cells with toluidine blue. Quantification of empty lacunae required following up of individual lacunae on serial sections to eliminate cases of lacunae that appeared empty, but contained a cell out of the original plane of section, as described by Farnum and Wilsman (1987) .
Ultrastructural Analysis
Seven tissue samples of each genotype were further processed for electron microscopy analysis. Blocks were restricted to the growth plate of the distal extremity of the femur. Ultrathin sections of Epon-embedded epiphyseal cartilage were placed on copper grids and contrasted with uranyl acetate and lead citrate and examined in a Philips electron microscope (EM 201) (Service de Microscopie Electronique, IFR Biologie Integrative, Paris VI, Jussieu, France). 
Probes for in Situ Hybridization
In Situ Hybridization
In situ hybridization experiments were performed as previously described (Colnot et al., 1999) .
RESULTS
As galectin 3 is strongly expressed in developing cartilage and bone, we analyzed the long bones of galectin 3 null mutant mice (Colnot et al., 1998) .
General Defects in the Galectin 3 Mutant
Epiphyseal Growth Plate Figure 1 shows the overall architecture of the distal extremity of the femur of wild-type and galectin 3 mutant embryos at E16.5 of gestation (Figs. 1A and 1B) . At this stage of development, the epiphyseal extremity is composed of round immature chondrocytes which become flattened and start to form longitudinal columns as they enter the proliferative zone in the growth plate. Subsequently, chondrocytes become mature and hypertrophic and are finally eliminated while lacunae are invaded by vascular cells.
A major defect was seen at the chondrovascular junction in the galectin 3 mutant, in which a large zone of empty lacunae could be observed between the last row of hypertrophic cells and the vascular invasion front (Fig. 1B) . A quantitative estimate of this defect was carried out on 11 wild-type and 13
FIG. 1.
Histology of the distal extremity of E16.5 wild-type (A) and galectin 3 mutant (B) femurs. E, epiphyseal extremity; p, proliferative zone; m, mature zone; h, hypertrophic zone; mp, metaphysis; pc, perichondrium; po, periosteum. Many empty lacunae are present at the chondrovascular junction in mutant bone and a reduction of the hypertrophic zone is observed (compare double arrows on A and B). At this magnification, no abnormalities were detected in the proliferative and mature zones. Scale bar, 100m, A and B. mutant individuals and indicated that the empty lacunae were 3.7 times more frequent in the mutant (Table 1) . Concomitantly, the mutant hypertrophic zone was reduced in size (Fig. 1B) in comparison with the wild type ( Fig. 1A ) and there were 20% fewer hypertrophic cells (Table 1 ). This reduction of the hypertrophic zone was equal to the enlargement of the zone of empty lacunae, such that the overall lengths of the entire embryonic epiphyseal cartilage were similar in wild type and mutant.
Molecular Analysis of the Galectin 3 Mutant Developing Long Bones
To determine if abnormalities in the galectin 3 mutant growth plate could be correlated with defects at the molecular level, we analyzed the expression of genes which are markers of cartilage and bone development. Representative results of in situ hybridization experiments on median sections of E16.5 tibias are shown in Fig. 2 .
As previously reported (Colnot et al., 1999) , galectin 3 transcripts are normally abundant in the proliferative, mature, and hypertrophic chondrocytes and are barely detectable in late hypertrophic chondrocytes ( Fig. 2A) . No galectin 3 transcripts were seen in galectin 3 null mutant bones (Fig. 2I) .
No noticeable differences were seen in the expression patterns of several markers of chondrocytes and bone cells: PTHrP receptor, a marker of proliferative chondrocytes (Figs. 2B and 2J); Bmp6, a marker of early hypertrophic chondrocytes (Figs. 2D and 2L); collagen X, a marker of hypertrophic chondrocytes (Figs. 2E and 2M); Cbfa/Osf2, which is expressed in chondrocytes and osteoblasts (Figs. 2F and 2N); OP, which encodes a secreted phosphoprotein localized in late hypertrophic cells and in osteoblastic cells (Figs. 2G and 2O) ; and MMP9, which is expressed in osteoclasts (Figs. 2H and 2P) . In contrast, Ihh expression was different in wild-type and mutant cartilage. In the growth plate of wild-type E16.5 tibias, Ihh was expressed in the mature and hypertrophic zones, but chondrocytes located at the center of the mature zone had lower levels of these transcripts than more lateral cells (Fig. 2C) . In the mutant, Ihh expression was still restricted to the mature and hypertrophic zones, but the distribution of the transcripts was more uniform across the width of the bone (Fig.  2K ). The Ihh signal was stronger in the center of the mature and early hypertrophic zones of mutant bones than in the Note. Counts were obtained from three paramedian sections of each E16.5 femur (wild type n ϭ 11; mutant n ϭ 13). Statistical analysis indicates that there are fewer hypertrophic chondrocytes (P Ͻ 0.0003, Mann-Whitney), more empty lacunae (P Ͻ 0.0001, t test), and more condensed cells (P Ͻ 0.0001, t test) in mutant cartilage.
FIG. 2.
In situ hybridization analysis of cartilage and bone markers in the growth plate of E16.5 tibias from wild-type and galectin 3 mutant embryos. Galectin 3 (A, I), PTHrP receptor (B, J), Ihh (C, K), Bmp6 (D, L), collagen X (E, M), Cbfa1/Osf2 (F, N), osteopontin (G, O), and MMP9/gelatinase B (H, P) on wild-type (A-H) and mutant (I-P) tibias. Note that Ihh mRNA distribution is altered in the mutant growth plate compared to the wild type (see arrows in C and K). Scale bar, 200 m, A-P. equivalent region of the wild-type bones (Figs. 2C and 2K, see arrows) . This was a consistent finding observed in all tested E16.5 tibias (n ϭ 6).
Analysis of the Epiphyseal Growth Plate Cartilage in Galectin 3 Mutants
Wild-type and mutant embryonic growth plates were compared by light and electron microscopy to understand how defects in chondrocyte differentiation could lead to the major abnormalities observed at the chondrovascular junction and to the modification of Ihh expression pattern.
Light microscopy. High-magnification pictures of the hypertrophic zones from two wild-type and four mutant femurs are presented in Fig. 3 . In wild-type bones, terminal hypertrophic cells were in close contact with blood or endothelial cells and truly empty lacunae were rarely observed (Figs. 3A and 3G ). The equivalent zones from four separate mutant individuals are shown in Figs. 3B, 3C, 3D, and 3H. The height of the zone of empty lacunae varied between one or two cell layers thick depending upon individuals. Although devoid of live cells, cellular debris could sometimes be found in some of these lacunae (Fig.  3B ). The majority of the last transverse septa were lacking (Figs. 3B, 3C, 3D, and 3H).
Several abnormalities were also seen in mutant chondrocytes. The volume of mutant hypertrophic cells was generally larger than that of wild-type cells and their cytoplasm was more vacuolated (Figs. 3B, 3C, 3D , and 3H; compare with Figs. 3A and 3G). Concomitantly, we observed an enlargement of the lacunae. Furthermore, this increase in size of vacuoles started earlier during the process of hypertrophy in the mutant. Indeed, very large and highly vacuolated cells, characteristic of the hypertrophic zone, were occasionally seen at the transition between the mature and the hypertrophic zones of the mutant (Fig. 3F ). This indicated a sporadic asynchrony during the process of hypertrophy. In addition, some large mutant cells had an abnormal aspect characterized by a distended cytoplasm filled with basophilic material and the absence of cell processes (Fig.  3D) . Cartilage matrix mineralization was visualized as an intense toluidine blue staining of the longitudinal septa in Figs. 3G and 3H. The staining was less intense and more patchy in the mutant (Fig. 3H ) than in the wild type (Fig.  3G ), indicating that this process was also disturbed in the absence of galectin 3. Moreover, calcified cartilage matrix appeared only in the last two layers of hypertrophic mutant chondrocytes (Fig. 3H) , while it normally spans half the height of the hypertrophic zone (Fig. 3G) , suggesting a delay in mineralization in the mutant.
In the late hypertrophic zone of mutant growth plates, nonhypertrophied chondrocytes could be observed (Figs. 3B,  3C , and 3D). These cells were small, very condensed, and strongly stained with toluidine blue and the majority of them were found in the terminal lacunae. Some of them had an asymmetrical attachment to the last transverse septum (Fig. 3C) . A quantitative estimate of these condensed cells is reported in Table 1 and it appeared that in the mutant, the number of cells of this type was double that found in the wild-type samples. Electron microscope study. We then undertook a more detailed study at the ultrastructural level to further analyze these condensed cells and other defects associated with the galectin 3 mutation. Figure 4 shows two examples of condensed chondrocytes from galectin 3 mutant late hypertrophic zones, similar to those shown by light microscopy in Fig. 3 . Typically, the plasma membrane was withdrawn from its attachment to the pericellular matrix and had only one asymmetrical attachment point to the last transverse septum (Fig. 4A) . The plasma membrane seemed not to be disrupted. The cytoplasmic content was unusually condensed, although the nucleus was not. Patchy condensations of the chromatin were observed and large vacuoles had formed inside the nucleus (Fig. 4A) .
Condensed cells were not exclusively found at the chondrovascular junction of galectin 3 mutants but also above, in the hypertrophic zone (Fig. 4B ). These cells did not appear to be asymmetrically attached to the longitudinal or transverse septum. The cytoplasmic content was also highly condensed and displayed large glycogen deposits. The nucleus had an irregular shape and the chromatin was condensed (Fig. 4B) .
Further abnormalities associated with chondrocyte hypertrophy were found in the extracellular matrix and at the cell-matrix interface. The mutant sample in Fig. 5B shows distended hypertrophic cells that, unlike normal chondrocytes (Fig. 5A) , did not form cell processes and exhibited a smooth membrane. The cytoplasm of these galectin 3 mutant chondrocytes contains large amounts of electrondense material compared to the wild type (Figs. 5A and 5B). In contrast, the density of the lacunae content surrounding the mutant chondrocyte was very low, suggesting that components that should be secreted are abnormally accumulating inside the cell (Fig. 5B) . Moreover, the structure of the extracellular matrix was irregular in the mutant compared to the wild type (Figs. 5C and 5D ). In some regions, the extracellular matrix was less dense and collagen fibers were missing in the center of the longitudinal columns (Fig.  5D ). The collagen fibers were also disrupted and their length was shorter. There appeared to be a slight reduction in the number of proteoglycan granules along and between the collagen fibers in the mutant cartilage (Fig. 5D ). Mutant matrix vesicles had an irregular size and shape, and many of them appeared empty (Fig. 5F ) compared to the wild type (Fig. 5E ). As matrix vesicles play a role in matrix mineralization, this defect might account for the reduction of the zone of calcified cartilage observed by light microscopy (see Fig. 3 ).
Disorders due to the galectin 3 mutation were also observed in the proliferative zone. As seen in Fig. 1 , cells in the mutant proliferating zone were normally organized in longitudinal columns similar to the wild-type cells. Mutant proliferating chondrocytes were flattened and polarized, nuclei were characteristically localized at one extremity of the cytoplasm, and the secretory system was well developed as in the normal sample (Figs. 6A and 6B ). However, very large areas of an electron-dense material were present at the extremities of the mutant cells (Fig. 6B) . These deposits displayed the characteristic granular structure of glycogen (Fig. 6C) . Normal chondrocytes contain glycogen particles scattered throughout the cytoplasm (Fig. 6A) , but large aggregates as seen in the galectin 3 mutant rarely formed. Large aggregates of glycogen deposits were also present in mutant hypertrophic chondrocytes (Fig. 6E ), but not in wild-type chondrocytes (Fig. 6D ). This phenomenon was also observed in the mutant condensed chondrocytes (Figs. 4A and 4B ). These observations indicate that glycogen is either overproduced or not properly degraded and metabolized in galectin 3 mutant chondrocytes.
DISCUSSION
Pleiotropic Defects in Chondrocyte Differentiation
Morphological and molecular analysis revealed several abnormalities in the sequence of chondrocyte differentiation events in the galectin 3 null mutant growth plate. The earliest defect is the accumulation of very large glycogen deposits found in the cytoplasm of mutant proliferative chondrocytes, as well as in mature and hypertrophic chon- drocytes. Glycogen is an important source of energy for cells in the cartilage, which is an avascular tissue, and chondrocytes are hyperactive cells that simultaneously synthesize and use glycogen (Townsend and Gibson, 1970 ). It appears that this balance of glycogen synthesis and degradation is perturbed in the galectin 3 mutants. Concomitantly, mutant hypertrophic chondrocytes were generally bigger and more vacuolated than wild-type hypertrophic cells, suggesting that there is an altered metabolic activity in these cells. In addition, the presence of very large cells that did not exhibit cell processes and that contained abnormally high amounts of basophilic material are indicative of an impaired secretion. This defect may partly account for the abnormal structure and composition of the cartilage matrix and ultimately contribute to the defect of matrix mineralization. All these various abnormalities did not detectably affect the expression pattern of several cartilage and bone markers with the exception of Ihh, which was slightly upregulated in galectin 3 mutants. The mechanism by which galectin 3 impinges on the regulation of this key signaling molecule in bone formation remains unclear.
It is likely that these various cellular and molecular defects reflect multiple functions of galectin 3 in chondrogenesis. Thus, galectin 3 might have a role in the rate of chondrocyte differentiation and its absence might induce a slight acceleration of this process, which finally results in a significant reduction of the number of cells in the hypertrophic zone. This possibility is supported by the fact that some mutant chondrocytes enter hypertrophy more quickly and independent of neighboring cells. Thus, the presence of occasional large and highly vacuolated hypertrophic cells at the level of the prehypertrophic zone suggests that the mutation has a cell-autonomous effect on the rate of differentiation which is consistent with the cytoplasmic localization of galectin 3 in these cells (Colnot et al., 1999) . As reported in PTHrP null mutant mice (Amizuka et al., 1994) , defective signaling between adjacent cells may lead to sporadic asynchrony in chondrocyte differentiation.
Is There Increased Cell Death in Galectin 3 Mutant Chondrocytes?
When we investigated the consequences of these abnormalities in terminal differentiation of chondrocytes at the chondrovascular junction, we noticed a higher number of condensed chondrocytes in the mutant late hypertrophic zone. It is formally possible that these chondrocytes may be transdifferentiating into osteoblast-like cells as has been previously proposed based on in vitro studies (Roach et al., 1995) and in vitamin D-deficient rats (Balmain et al., 1992) . However, the most likely interpretation is that these condensed chondrocytes are in the process of entering cell death, which is consistent with the high incidence of empty lacunae and the reduced number of hypertrophic chondrocytes. Moreover, in swine, condensed chondrocytes have previously been interpreted as a late stage of chondrocyte differentiation before their elimination and the subsequent invasion of the lacunae by vascular cells Wilsman, 1987, 1989b) . These studies suggest that the majority of chondrocytes undergoes a condensation phase even though only a small proportion of terminal chondrocytes appears condensed, indicating that this phase is very rapid.
In addition, our observations at the ultrastructural level show that dense chondrocytes in the galectin 3 growth plate actually exhibit signs of cell death. There is a reduction in the cell volume, a high concentration of cytoplasmic content, and a condensation of the chromatin. However, we never noticed fragmentation of the nucleus or the formation of apoptotic bodies that are phagocytosed by other cells as is usually seen during the process of apoptosis. Although it has been generally accepted that chondrocytes die by apoptosis in vivo (Gibson et al., 1995; Bronckers et al., 1996; Aizawa et al., 1997) , the condensed cells that we have observed in the E16.5 mouse fetuses do not display all the characteristic features of apoptotic cells. Moreover, we did not detect TUNEL-positive cells at the chondrovascular junction of E16.5 femurs (data not shown), indicating that DNA fragmentation is not an appropriate criterion to monitor the late stages of murine chondrocyte death. Interestingly, Roach and Clarke (2000) have recently shown that in the rabbit growth plate, chondrocyte death does not involve apoptosis, but another type of physiological cell death characterized by the presence of condensed and strongly stained cells that they named "dark" chondrocytes. These dark chondrocytes seem to eliminate themselves by a mechanism similar to lysosomal or type 2 programmed cell death (Clarke, 1990) . The condensed chondrocytes that we describe here are likely to be the murine equivalent of rabbit dark chondrocytes. Therefore, it appears that mouse hypertrophic chondrocytes die by an alternative pathway, which differs from classical apoptosis, and that the absence of galectin 3 accelerates this process.
Coordination between Cell Death and Metaphyseal Invasion Is Perturbed at the Chondrovascular Junction in the Galectin 3 Mutant
The main feature of the galectin 3 mutant growth plate is the abnormal chondrovascular junction where a high amount of empty lacunae has been quantified. Even if there were differences between individuals, penetrance of the phenotype was 100%, i.e., all tested mutants were affected.
Previous studies have described that the number of empty lacunae as well as the number of condensed cells reflect cellular turnover at the chondrovascular junction in the pig growth plate (Farnum and Wilsman, 1989a,b) . The high quantity of empty lacunae observed in the galectin 3 mutant could be explained by a higher cellular turnover as a consequence of the increased rate of chondrocyte death. However, the fact that these lacunae are not rapidly invaded by vascular cells indicates that there is also an asynchrony between chondrocyte death and metaphyseal invasion. Both phenomena are uncoupled in the galectin 3 mutant. For a long time, it was not known whether programmed cell death of chondrocytes was an intrinsic process, i.e., the ultimate stage of programmed chondrocyte differentiation, or whether it was induced by signals coming from the metaphysis. On one hand, the mechanism of selfelimination that we observed can be taken in favor of the first hypothesis. Furthermore, several studies have suggested that there is an intracellular regulation of chondrocyte death in vivo by molecules implicated in programmed cell death, like the proto-oncogene Bcl-2 and Bax (Amling et al., 1997; Wang et al., 1997) . On the other hand, analysis of mice lacking the MMP9 gene showed that chondrocyte death also depends upon signals coming from the metaphysis, suggesting that there is a cross talk between chondro-cytes and vascular cells (Vu et al., 1998) . That cell death and metaphyseal invasion are no longer coordinated in the galectin 3 mutant may thus indicate that in addition to the intrinsic defects in mutant chondrocytes, this cross talk is also defective.
This uncoupling is similar to the phenotype observed in conditional mutants in which cells expressing collagen 2a1 lack VEGF-A (Haigh et al., 2000) . In these mutants, the vascular invasion of hypertrophic cartilage is decreased, showing that the secretion of VEGF by hypertrophic chondrocytes is required to allow migration of endothelial cells into the empty lacunae. In the case of the galectin 3 mutants, there may be a defect of signaling from the chondrocytes to the vascular cells which would trigger invasion of the lacunae and/or a defect of signaling from the metaphysis to the chondrocytes that would induce increased cell death without increasing the rate of invasion. Although we did not detect any difference in the expression of bone cell markers such as osteopontin, Cbfa, or MMP9, detailed structural analysis in the metaphysis may help address this question. Indeed we have also described the expression of galectin 3 in the osteoblasts and osteoclasts of the metaphysis (Colnot et al., 1999) , so it remains possible that some functions of these cells are also altered in the absence of galectin 3.
What Could Be the Function of Galectin 3 in Endochondral Bone Formation?
The sequence of events which occur during the remodeling of cartilage into bone are not yet well understood. Normal cartilage differentiation and degradation is required for bone deposition. Despite the fact that chondrocyte hypertrophy and the chondrovascular junction are both perturbed in the galectin 3 mutant fetal bones, we did not notice any significant difference in the final size of long bones using standard X-ray analysis on adult animals (data not shown). This observation suggests that the early defects are transient, as has been observed in the MMP9 null mutant mice (Vu et al., 1998) . However, this does not preclude that some abnormalities might occur under stress conditions such as bone healing.
In summary, we have shown that during embryogenesis, the galectin 3 null mutation has several effects on chondrocyte differentiation, most notably premature cell death of chondrocytes without concomitant vascular invasion. One of the roles of galectin 3 could be a survival factor for chondrocytes. Interestingly, galectin 3 has been shown to be an antiapoptotic molecule in T-lymphocytes and human breast epithelial cells in which it acts in the same pathway as other antiapoptotic molecules, like Bcl-2 (Yang et al., 1996; Akahani et al., 1997) . There might also be a functional interaction between galectin 3 and Bcl-2 during bone formation since both molecules are present in the cytoplasm of mature and early hypertrophic chondrocytes (Colnot et al., 1999; Amling et al., 1997; Wang et al., 1997) . However, the pleiotropic defects indicate that galectin 3 may well operate at several levels. Thus, uncoupling between chondrocyte death and vascular invasion could possibly result from a role of galectin 3 as an adhesion or a signaling molecule promoting vascular invasion since it has recently been shown to induce endothelial cell morphogenesis and angiogenesis in vivo (Nangia-Makker et al., 2000) .
In conclusion, this analysis has not only revealed that galectin 3 is part of multiple molecular interactions that occur at the chondrovascular junction, but it has also brought new insights into the mechanisms regulating endochondral bone formation.
